Public health impact of changes in smoking behavior - Results from the tobacco policy model

被引:32
作者
Tengs, TO [1 ]
Osgood, ND [1 ]
Lin, TH [1 ]
机构
[1] Univ Calif Irvine, Sch Social Ecol, Hlth Prior Res Grp, Irvine, CA 92697 USA
关键词
tobacco; smoking; simulation; quality of life;
D O I
10.1097/00005650-200110000-00010
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
OBJECTIVES. The relative magnitude of the public health gains from preventing smoking initiation versus encouraging cessation or avoiding relapse in different ages and genders is estimated and compared. METHODS. Health gains are defined as the predicted increase in Quality-Adjusted Life Years (QALYs) to the US population during a century. To estimate QALYs, we developed the Tobacco Policy Model. The model simulates a 10% reduction in the annual probability of initiation versus a 10% increase in cessation versus a 10% reduction in relapse in males and females in six age groups: 10 to 19, 20 to 29, 30 to 39, 40 to 49, 50 to 59 and 60 to 69. RESULTS. Among youth and young adults, reducing initiation yields far more QALYs than encouraging cessation or averting relapse. In middle-aged adults, cessation yields the most QALYs, followed by averting relapse and reducing initiation. In the oldest age group, averting relapse yields the most QALYs followed by cessation and reducing initiation. In general, increasing cessation and reducing relapse is more beneficial in males than in females whereas reducing initiation is more beneficial in females. CONCLUSIONS. The relative value of preventing initiation, encouraging cessation, and averting relapse differs by age and gender. Reducing initiation in youth is likely to offer the largest public health impact during the next century.
引用
收藏
页码:1131 / 1141
页数:11
相关论文
共 23 条
[1]  
[Anonymous], 1993, MIT DIS HLTH FAC
[2]  
*CDCP, 1995, NAT SCH BAS YOUTH RI
[3]  
*CDCP, 1993, MMWR-MORBID MORTAL W, V42, P645
[4]  
Centers for Disease Control and Prevention, 1995, BEH RISK FACT SURV S
[5]  
Centers for Disease Control and Prevention, 1992, NAT HLTH NUTR EX SUR
[6]   Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation [J].
Cromwell, J ;
Bartosch, WJ ;
Fiore, MC ;
Hasselblad, V ;
Baker, T .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (21) :1759-1766
[7]  
ERICKSON P, 2000, HLTH PEOPLE 2000 STA, V7
[8]   Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling [J].
Fiscella, K ;
Franks, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (16) :1247-1251
[9]  
Gold MR, 1996, COST EFFECTIVENESS H
[10]  
Kaplan R., 1993, The Hippocratic Predicament: Affordability, access, and accountability in American health care